Authors
Latest:
At CIME 2025, Luke Lindsell, OD, MD, shares thoughts on comanaging challenging retina casesIn this Q&A, Luke Lindsell, OD, MD, shares his insights on emerging therapies in retina, the evolving role of optometrists in retinal disease management, and the importance of comanagement in patient care.
Latest:
CIME 2025: Wendy Lee, MD, MS, emphasizes the power of a referral to an oculoplastics surgeonWendy Lee, MD, MS, shares how she integrates aesthetic and functional care in oculoplastics.
Latest:
What’s Your WhEYE? A conversation with Paul Badawi, CEO of Sight SciencesPaul Badawi, co-founder and CEO of Sight Sciences, sits down with host Neda Shamie, MD, to discuss his journey into the field of eye care, what motivates him, the transformative approach to glaucoma patient care, and the spark that led him and his ophthalmologist brother, David Badawi, MD, to start the company together.
Latest:
Transforming the eye with a new standard for corneal cross-linkingThe new standard: Stabilizing keratoconus and improving vision.
Latest:
ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL casesUse of the LENSAR Ally femtosecond laser for arcuate incisions was associated with improved early visual outcomes and reduced need for postoperative adjustments in premium IOL patients.
Latest:
ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomesA machine learning model using treated astigmatism and other nuanced inputs can significantly improve the accuracy and personalization of arcuate keratotomy planning
Latest:
Envision Summit 2025: Pearls for pediatric cataract surgeryAt the Envision Summit 2025 in San Juan, Puerto Rico, Angela Zhu, MD, offered advice on cataract surgery for all ages, focusing on pediatrics.
Latest:
MIGS helping to personalize glaucoma surgery optionsAlthough minimally invasive procedure gives hope, additional research is required.
Latest:
Evolution of optical coherence tomography of the human eyeAdolf Fercher's 2D image of fundus paved way for today’s imaging technique.
Latest:
A roadmap to preserving the prime years of patients diagnosed with MacTelAccording to Thomas Aaberg, MR, the novel therapy is geared to treat rare, debilitating eye disease.
Latest:
Diagnostic Maze: Navigating the complexity of isolated optic disc edema in syphilitic uveitisWith cases of syphilitic uveitis on the rise, recognizing its varied presentations—including optic disc edema, which may appear without other significant eye inflammation—is increasingly important for timely diagnosis and treatment.
Latest:
The future of decentralized clinical trials in ophthalmologyResearch can drive opportunities for patients with rare diseases
Latest:
Fulfilling expectations: A super highway to workabilityA powerful conversation about expectations can open communication and trust.
Latest:
Adherence and tolerability are key in treatment of hypertension and glaucomaPriorities can ensure optimal outcomes for patients diagnosed with diseases.
Latest:
Impressions and Takeaways From Patient Case #2Daniel F Kiernan, MD, FACS, discusses the use of anti-inflammatory treatment when experiencing sub-optimal response with anti-VEGF therapy in DME.
Latest:
Diagnostic Maze: Navigating the complexity of isolated optic disc edema in syphilitic uveitisWith cases of syphilitic uveitis on the rise, recognizing its varied presentations—including optic disc edema, which may appear without other significant eye inflammation—is increasingly important for timely diagnosis and treatment.
Latest:
Envision Summit 2025: Retinal imaging to diagnose and identify neurodegenerative diseases using machine learning.At the Envision Summit 2025 in San Juan, Puerto Rico, Sharon Fekrat, MD, FACS, FASRS talked about multi-modal retinal and choroidal imaging to diagnose and identify neurodegenerative diseases using machine learning.
Latest:
Study finds sublingual troche, IV sedation are equivalent for cataract surgeryThe method by which sedation is applied to keep patients relaxed and comfortable throughout cataract surgery can be tailored similar to that of anesthesia — surgical anesthesia is not a one size fits all endeavor.
Latest:
DMEI resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO posterOoms' poster at the Association of University Professors of Ophthalmology annual meeting highlighted a study on gray area complications in strabismus surgery, showing that trainees are more likely than attendings to disclose these complications despite having similar baseline anxiety levels. Ooms is a PGY-4 ophthalmology resident at the Dean McGee Eye Institute.
Latest:
Artificial DMEK could help tackle endothelial donor tissue shortageNew acrylic implant provides option for patients with endothelial dysfunction.
Latest:
Topical presbyopic correction: a postoperative problem solverPresbyopia-correcting drops represent a whole new product category—one with a lot of upsides for clinicians who want to help their patients see well at all distances.
Latest:
Should nonclinicians inject dexamethasone implants?Studies on nurse-led services find a low level of complications among patients.
Latest:
Advantages of incorporating ECP into the surgeon’s armamentariumShort learning curve, significant clinical advantages make this a comfortable addition.
Latest:
What ophthalmologists need to know about neuromyelitis optica spectrum disorderEarly diagnosis of NMOSD is key to preventing disability, improving survival.
Latest:
Clearing hurdles to large scale telemedicine adoptionDuring the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye
Latest:
ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTSConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwideAnswers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
Latest:
ARVO 2025: First in-human clinical trials results from magnetic cell therapyEllen Koo, MD, presented data from first in-human clinical trials, looking at the results from magnetic cell therapy and reports on the efficacy and safety in the patients.
Latest:
Long-Term Outcomes After Nonimplant MIGS ProcedureA panelist discusses how nonimplant MIGS, such as viscocanaloplasty and viscoelastic delivery devices, offer long-term IOP reduction and medication savings, emphasizing their benefits for early intervention and improved postoperative quality of life, while noting limitations for more advanced glaucoma conditions.
